Galenica Sante Ag Stock Return On Equity
GALE Stock | CHF 70.55 0.55 0.79% |
Galenica Sante AG fundamentals help investors to digest information that contributes to Galenica Sante's financial success or failures. It also enables traders to predict the movement of Galenica Stock. The fundamental analysis module provides a way to measure Galenica Sante's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Galenica Sante stock.
Galenica |
Galenica Sante AG Company Return On Equity Analysis
Galenica Sante's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Galenica Sante Return On Equity | 0.15 |
Most of Galenica Sante's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Galenica Sante AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, Galenica Sante AG has a Return On Equity of 0.1509. This is 100.63% lower than that of the Healthcare sector and 100.41% lower than that of the Biotechnology industry. The return on equity for all Switzerland stocks is 148.68% lower than that of the firm.
Galenica Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Galenica Sante's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Galenica Sante could also be used in its relative valuation, which is a method of valuing Galenica Sante by comparing valuation metrics of similar companies.Galenica Sante is currently under evaluation in return on equity category among related companies.
Galenica Fundamentals
Return On Equity | 0.15 | |||
Return On Asset | 0.0492 | |||
Profit Margin | 0.04 % | |||
Operating Margin | 0.05 % | |||
Current Valuation | 4.26 B | |||
Shares Outstanding | 49.64 M | |||
Shares Owned By Insiders | 0.17 % | |||
Shares Owned By Institutions | 49.77 % | |||
Price To Earning | 16.37 X | |||
Price To Book | 3.16 X | |||
Price To Sales | 0.94 X | |||
Revenue | 3.83 B | |||
Gross Profit | 427.92 M | |||
EBITDA | 305.98 M | |||
Net Income | 167.68 M | |||
Cash And Equivalents | 164.98 M | |||
Cash Per Share | 2.13 X | |||
Total Debt | 579.88 M | |||
Debt To Equity | 43.80 % | |||
Current Ratio | 1.77 X | |||
Book Value Per Share | 23.35 X | |||
Cash Flow From Operations | 333.1 M | |||
Earnings Per Share | 3.45 X | |||
Target Price | 70.0 | |||
Number Of Employees | 5.52 K | |||
Beta | 0.19 | |||
Market Capitalization | 3.74 B | |||
Total Asset | 2.57 B | |||
Z Score | 4.6 | |||
Annual Yield | 0.03 % | |||
Net Asset | 2.57 B | |||
Last Dividend Paid | 2.1 |
About Galenica Sante Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Galenica Sante AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galenica Sante using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galenica Sante AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galenica Sante AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Galenica Stock analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Stocks Directory Find actively traded stocks across global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |